Palavras-chave
Cognitive decline
Body composition
Como Citar
Resumo
Certain aspects of body composition can serve as predictors of cognitive impairment risk, enabling preventive interventions. Adipose tissue plays a complex role in cognitive health and dementia risk. This association appears to be influenced by age, sex and body fat distribution. However, factors like systemic inflammation and metabolic disturbances linked to obesity can negatively impact brain health. Muscle mass and strength are fundamental determinants of cognitive well-being. Interventions designed to increase muscle strength and to prevent muscular loss may hold promises for the maintenance of neurocognitive brain health, based on the role of myokines in pathophysiology and muscle-to-brain axis to healthy aging. Sarcopenia contributes to metabolic dysfunction, inflammation, and neuromuscular deterioration, potentially accelerating cognitive impairment. Sarcopenic obesity presents an elevated risk for adverse health outcomes, including cognitive decline and dementia. Maintaining an optimal balance between muscle and fat mass is crucial. Given these findings, promoting muscle health through resistance training and proper nutrition emerges as a key strategy in preventing cognitive impairment and fostering overall brain health.
Referências
Anand, S. S., Friedrich, M. G., Lee, D. S., Awadalla, P., Després, J. P., Desai, D., de Souza, R. J., Dummer, T., Parraga, G., Larose, E., Lear, S. A., Teo, K. K., Poirier, P., Schulze, K. M., Szczesniak, D., Tardif, J.-C., Vena, J., Zatonska, K., Yusuf, S., & Smith, E. E. (2022). Evaluation of Adiposity and Cognitive Function in Adults. JAMA Network Open, 5(2), e2146324. https://doi.org/10.1001/jamanetworkopen.2021.46324
Arosio, B., Calvani, R., Ferri, E., Coelho-Junior, H. J., Carandina, A., Campanelli, F., Ghiglieri, V., Marzetti, E., & Picca, A. (2023). Sarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle–Brain Axis. Nutrients, 15(8), 1853. https://doi.org/10.3390/nu15081853
Au, A., Feher, A., McPhee, L., Jessa, A., Oh, S., & Einstein, G. (2016). Estrogens, inflammation and cognition. Front. Neuroendocrinol., 40, 87–100. https://doi.org/10.1016/j.yfrne.2016.01.002
Beeri, M. S., Leugrans, S. E., Delbono, O., Bennett, D. A., & Buchman, A. S. (2021). Sarcopenia is associated with incident Alzheimer’s dementia, mild cognitive impairment, and cognitive decline. J. Am. Geriatr. Soc., 69(7), 1826–1835. https://doi.org/10.1111/jgs.17206
Beller, E., Lorbeer, R., Keeser, D., Schoeppe, F., Sellner, S., Hetterich, H., Bamberg, F., Schlett, C. L., Peters, A., Ertl-Wagner, B., & Stoecklein, S. (2019). Hepatic fat is superior to BMI, visceral and pancreatic fat as a potential risk biomarker for neurodegenerative disease. European Radiology, 29(12), 6662–6670. https://doi.org/10.1007/s00330-019-06276-8
Boccara, E., Golan, S., & Beeri, M. S. (2023). The association between regional adiposity, cognitive function, and dementia-related brain changes: a systematic review. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1160426
Calvani, R., Picca, A., Coelho-Júnior, H. J., Tosato, M., Marzetti, E., & Landi, F. (2023). Diet for the prevention and management of sarcopenia. Metabolism, 146, 155637. https://doi.org/10.1016/j.metabol.2023.155637
Cannavale, C. N., Bailey, M., Edwards, C. G., Thompson, S. V., Walk, A. M., Burd, N. A., Holscher, H. D., & Khan, N. A. (2021). Systemic inflammation mediates the negative relationship between visceral adiposity and cognitive control. International Journal of Psychophysiology, 165, 68–75. https://doi.org/10.1016/j.ijpsycho.2021.03.010
Cárdenas, D., Madinabeitia, I., Vera, J., de Teresa, C., Alarcón, F., Jiménez, R., & Catena, A. (2020). Better brain connectivity is associated with higher total fat mass and lower visceral adipose tissue in military pilots. Scientific Reports, 10(1), 610. https://doi.org/10.1038/s41598-019-57345-3
Chen, L. (2023). Aging, Body Composition, and Cognitive Decline: Shared and Unique Characteristics. J. Nutr. Health Aging, 27(11), 929–931. https://doi.org/10.1007/s12603-023-2022-x
Chen, W., Wang, L., You, W., & Shan, T. (2021). Myokines mediate the cross talk between skeletal muscle and other organs. J. Cell. Physiol., 236(4), 2393–2412. https://doi.org/10.1002/jcp.30033
Christensen, A., & Pike, C. J. (2015). Menopause, obesity and inflammation: Interactive risk factors for Alzheimer’s disease. Front. Aging Neurosci., 7. https://doi.org/10.3389/fnagi.2015.00130
Chung, C.-P., Lee, W.-J., Peng, L.-N., Shimada, H., Tsai, T.-F., Lin, C.-P., Arai, H., & Chen, L.-K. (2021). Physio-Cognitive Decline Syndrome as the Phenotype and Treatment Target of Unhealthy Aging. J. Nutr. Health Aging, 25(10), 1179–1189. https://doi.org/10.1007/s12603-021-1693-4
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., Zamboni, M., Bautmans, I., Baeyens, J. P., Cesari, M., … Schols, J. (2019). Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing, 48(1), 16–31. https://doi.org/10.1093/ageing/afy169
Emmerzaal, T. L., Kiliaan, A. J., & Gustafson, D. R. (2015). 2003-2013: A decade of body mass index, Alzheimer’s disease, and dementia. J. Alzheimers Dis., 43(3), 739–755. https://doi.org/10.3233/JAD-141086
Esteban‐Cornejo, I., Ho, F. K., Petermann‐Rocha, F., Lyall, D. M., Martinez‐Gomez, D., Cabanas‐Sánchez, V., Ortega, F. B., Hillman, C. H., Gill, J. M. R., Quinn, T. J., Sattar, N., Pell, J. P., Gray, S. R., & Celis‐Morales, C. (2022). Handgrip strength and all‐cause dementia incidence and mortality: findings from the UK Biobank prospective cohort study. Journal of Cachexia, Sarcopenia and Muscle, 13(3), 1514–1525. https://doi.org/10.1002/jcsm.12857
Evans, W. J., Guralnik, J., Cawthon, P., Appleby, J., Landi, F., Clarke, L., Vellas, B., Ferrucci, L., & Roubenoff, R. (2023). Sarcopenia: no consensus, no diagnostic criteria, and no approved indication—How did we get here? GeroScience, 46(1), 183–190. https://doi.org/10.1007/s11357-023-01016-9
Farr, S. A., Banks, W. A., & Morley, J. E. (2006). Effects of leptin on memory processing. Peptides, 27(6), 1420–1425. https://doi.org/10.1016/j.peptides.2005.10.006
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., Fisher, J. L., Fitzmaurice, C., Giussani, G., Glennie, L., James, S. L., Johnson, C. O., Kassebaum, N. J., Logroscino, G., Marin, B., … Vos, T. (2019). Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol., 18(5), 459–480. https://doi.org/10.1016/S1474-4422(18)30499-X
Fernandez‐Martos, C. M., Atkinson, R. A. K., Chuah, M. I., King, A. E., & Vickers, J. C. (2017). Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer’s disease. Alzheimers Dement. (N Y), 3(1), 92–106. https://doi.org/10.1016/j.trci.2016.11.002
Fewlass, D. C., Noboa, K., Pi‐Sunyer, F. X., Johnston, J. M., Yan, S. D., & Tezapsidis, N. (2004). Obesity‐related leptin regulates Alzheimer’s Aβ. The FASEB Journal, 18(15), 1870–1878. https://doi.org/10.1096/fj.04-2572com
Gerber, Y., VanWagner, L. B., Yaffe, K., Terry, J. G., Rana, J. S., Reis, J. P., & Sidney, S. (2021). Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study. BMC Gastroenterology, 21(1), 96. https://doi.org/10.1186/s12876-021-01681-0
Holden, K. F., Lindquist, K., Tylavsky, F. A., Rosano, C., Harris, T. B., & Yaffe, K. (2009). Serum leptin level and cognition in the elderly: Findings from the Health ABC Study. Neurobiol. Aging, 30(9), 1483–1489. https://doi.org/10.1016/j.neurobiolaging.2007.11.024
James, B. D., & Bennett, D. A. (2019). Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer’s Disease. Annu. Rev. Public Health, 40, 65–84. https://doi.org/10.1146/annurev-publhealth
Jensen, G. L. (2008). Inflammation: Roles in Aging and Sarcopenia. J. Parenter. Enteral Nutr., 32(6), 656–659. https://doi.org/10.1177/0148607108324585
Kang, S. H., Lee, K. H., Chang, Y., Choe, Y. S., Kim, J. P., Jang, H., Shin, H. Y., Kim, H. J., Koh, S.-B., Na, D. L., Seo, S. W., & Kang, M. (2022). Gender-specific relationship between thigh muscle and fat mass and brain amyloid-β positivity. Alzheimer’s Research & Therapy, 14(1), 145. https://doi.org/10.1186/s13195-022-01086-5
Kaye, J. A., Swihart, T., Howieson, D., Dame, A., Moore, M. M., Karnos, T., Camicioli, R., Ball, M., Oken, B., & Sexton, G. (1997). Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology, 48(5), 1297–1304. https://doi.org/10.1212/WNL.48.5.1297
Khadra, D., Itani, L., Tannir, H., Kreidieh, D., Masri, D. El, & Ghoch, M. El. (2019). Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: A systematic review and meta-analysis. World Journal of Diabetes, 10(5), 311–323. https://doi.org/10.4239/wjd.v10.i5.311
Kim, S., Choi, J.-Y., Moon, S., Park, D.-H., Kwak, H.-B., & Kang, J.-H. (2019). Roles of myokines in exercise-induced improvement of neuropsychiatric function. Pflugers Arch., 471(3), 491–505. https://doi.org/10.1007/s00424-019-02253-8
Kim, S. M., Choi, S., Lee, G., Oh, Y. H., Son, J. S., Ko, A., Kim, J. S., Cho, Y., Keum, N., & Park, S. M. (2024). Association of changes in predicted body composition with subsequent risk of dementia. Annals of Clinical and Translational Neurology, 11(8), 1952–1963. https://doi.org/10.1002/acn3.52096
Kim, S., Yi, H.-A., Won, K. S., Lee, J. S., & Kim, H. W. (2022). Association between Visceral Adipose Tissue Metabolism and Alzheimer’s Disease Pathology. Metabolites, 12(3), 258. https://doi.org/10.3390/metabo12030258
Knopman, D. S., Edland, S. D., Cha, R. H., Petersen, R. C., & Rocca, W. A. (2007). Incident dementia in women is preceded by weight loss by at least a decade. Neurology, 69(8), 739–746. https://doi.org/10.1212/01.wnl.0000267661.65586.33
Lee, G., Chang, J., Hwang, S., Son, J. S., & Park, S. M. (2021). Development and validation of prediction equations for the assessment of muscle or fat mass using anthropometric measurements, serum creatinine level, and lifestyle factors among Korean adults. Nutrition Research and Practice, 15(1), 95. https://doi.org/10.4162/nrp.2021.15.1.95
Lee, H., Seo, H. S., Kim, R. E. Y., Lee, S. K., Lee, Y. H., & Shin, C. (2021). Obesity and muscle may have synergic effect more than independent effects on brain volume in community-based elderly. European Radiology, 31(5), 2956–2966. https://doi.org/10.1007/s00330-020-07407-2
Li, J., Joshi, P., Ang, T. F. A., Liu, C., Auerbach, S., Devine, S., & Au, R. (2021). Mid-to Late-Life Body Mass Index and Dementia Risk: 38 Years of Follow-up of the Framingham Study. Am. J. Epidemiol., 190(12), 2503–2510. https://doi.org/10.1093/aje/kwab096
Lin, A., Wang, T., Li, C., Pu, F., Abdelrahman, Z., Jin, M., Yang, Z., Zhang, L., Cao, X., Sun, K., Hou, T., Liu, Z., Chen, L., & Chen, Z. (2023). Association of Sarcopenia with Cognitive Function and Dementia Risk Score: A National Prospective Cohort Study. Metabolites, 13(2), 245. https://doi.org/10.3390/metabo13020245
Liu, Y., Hanson, K. A., McCormack, G., Atkinson, R. A. K., Dittmann, J., Vickers, J. C., Fernandez-Martos, C. M., & King, A. E. (2021). Enhanced Anti-Amyloid Effect of Combined Leptin and Pioglitazone in APP/PS1 Transgenic Mice. Curr. Alzheimer Res., 17(14), 1294–1301. https://doi.org/10.2174/1567205018666210218163857
Małkiewicz, M. A., Szarmach, A., Sabisz, A., Cubała, W. J., Szurowska, E., & Winklewski, P. J. (2019). Blood-brain barrier permeability and physical exercise. J. Neuroinflammation, 16(1), 15. https://doi.org/10.1186/s12974-019-1403-x
Mazzoccoli, G., Dagostino, M. P., Vinciguerra, M., Ciccone, F., Paroni, G., Seripa, D., Addante, F., Montella, R. C., De Cosmo, S., Sera, F., & Greco, A. (2014). An association study between epicardial fat thickness and cognitive impairment in the elderly. American Journal of Physiology-Heart and Circulatory Physiology, 307(9), H1269–H1276. https://doi.org/10.1152/ajpheart.00175.2014
Mooldijk, S. S., de Crom, T. O. E., Ikram, M. K., Ikram, M. A., & Voortman, T. (2023). Adiposity in the older population and the risk of dementia: The Rotterdam Study. Alzheimers Dement., 19(5), 2047–2055. https://doi.org/10.1002/alz.12888
Mooldijk, S. S., Ikram, M. K., & Ikram, M. A. (2022). Adiponectin, Leptin, and Resistin and the Risk of Dementia. J. Gerontol. A Biol. Sci. Med. Sci., 77(6), 1245–1249. https://doi.org/10.1093/gerona/glab267
Morawin, B., Tylutka, A., Bielewicz, F., & Zembron-Lacny, A. (2023). Diagnostics of inflammaging in relation to sarcopenia. Front. Public Health, 11. https://doi.org/10.3389/fpubh.2023.1162385
Morley, J. E. (2016). Frailty and sarcopenia in elderly. Wien. Klin. Wochenschr., 128, 439–445. https://doi.org/10.1007/s00508-016-1087-5
National Institutes of Health - National Institute on Aging. (n.d.). Alzheimer’s & Related Dementias: What Is Mild Cognitive Impairment? Retrieved January 10, 2024, from https://www.alzheimers.gov/alzheimers-dementias/mild-cognitive-impairment
Nichols, E., Steinmetz, J. D., Vollset, S. E., Fukutaki, K., Chalek, J., Abd-Allah, F., Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T. T., Al Hamad, H., Alahdab, F., Alanezi, F. M., Alipour, V., Almustanyir, S., Amu, H., Ansari, I., Arabloo, J., Ashraf, T., … Vos, T. (2022). Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health, 7(2), e105–e125. https://doi.org/10.1016/S2468-2667(21)00249-8
Oudbier, S. J., Goh, J., Looijaard, S. M. L. M., Reijnierse, E. M., Meskers, C. G. M., & Maier, A. B. (2022). Pathophysiological Mechanisms Explaining the Association Between Low Skeletal Muscle Mass and Cognitive Function. J. Gerontol. A Biol. Sci. Med. Sci., 77(10), 1959–1968. https://doi.org/10.1093/gerona/glac121
Pertesi, S., Coughlan, G., Puthusseryppady, V., Morris, E., & Hornberger, M. (2019). Menopause, cognition and dementia – A review. Post Reprod. Health, 25(4), 200–206. https://doi.org/10.1177/2053369119883485
Raji, C., Meysami, S., Hashemi, S., Garg, S., Akbari, M., Gouda, A., Chodakiewitz, Y., Nguyen, T., Niotis, K., Merrill, D., & Attariwala, R. (2023). Visceral and Subcutaneous Abdominal Fat Predict Brain Volume Loss at Midlife in 10,001 Individuals. Aging Dis., 15(4), 1831–1842. https://doi.org/10.14336/ad.2023.0820
Sabia, S., Fayosse, A., Dumurgier, J., Schnitzler, A., Empana, J.-P., Ebmeier, K. P., Dugravot, A., Kivimäki, M., & Singh-Manoux, A. (2019). Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study. BMJ, l4414. https://doi.org/10.1136/bmj.l4414
Sartori, A. C., Vance, D. E., Slater, L. Z., & Crowe, M. (2012). The impact of inflammation on cognitive function in older adults: Implications for healthcare practice and research. J. Neurosci. Nurs., 44(4), 206–217. https://doi.org/10.1097/JNN.0b013e3182527690
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021). Alzheimer’s disease. The Lancet, 397(10284), 1577–1590. https://doi.org/10.1016/S0140-6736(20)32205-4
Searcy, J. L., Phelps, J. T., Pancani, T., Kadish, I., Popovic, J., Anderson, K. L., & Thibault, O. (2012). Long‐term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer’s disease. J. Alzheimers Dis., 30(4), 943–961. https://doi.org/10.3233/JAD-2012-111661
Severinsen, M. C. K., & Pedersen, B. K. (2020). Muscle–Organ Crosstalk: The Emerging Roles of Myokines. Endocr. Rev., 41(4), 594–609. https://doi.org/10.1210/endrev/bnaa016
Stephens, T. W., Basinski, M., Bristow, P. K., Bue-Valleskey, J. M., Burgett, S. G., Craft, L., Hale, J., Hoffmann, J., Hsiung, H. M., Kriauciunas, A., MacKellar, W., Rosteck, P. R., Schoner, B., Smith, D., Tinsley, F. C., Zhang, X.-Y., & Heiman, M. (1995). The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature, 377(6549), 530–532. https://doi.org/10.1038/377530a0
United Nations Population Fund, & HelpAge International. (2012). Ageing in the Twenty-First Century: A Celebration and A Challenge. https://www.unfpa.org/sites/default/files/pub-pdf/Ageing%20report.pdf
VanWagner, L. B., Terry, J. G., Chow, L. S., Alman, A. C., Kang, H., Ingram, K. H., Shay, C., Lewis, C. E., Bryan, R. N., Launer, L. J., & Jeffrey Carr, J. (2017). Nonalcoholic fatty liver disease and measures of early brain health in middle‐aged adults: The CARDIA study. Obesity, 25(3), 642–651. https://doi.org/10.1002/oby.21767
Verrusio, W., Renzi, A., Magro, V., Musumeci, M., Andreozzi, P., & Cacciafesta, M. (2019). Association between epicardial fat thickness and cognitive function in elderly. A preliminary study. Ann Ist Super Sanita, 55, 59–62.
Wang, W., Luo, Y., Zhuang, Z., Song, Z., Huang, N., Li, Y., Dong, X., Xiao, W., Zhao, Y., & Huang, T. (2022). Total and regional fat-to-muscle mass ratio and risks of incident all-cause dementia, Alzheimer’s disease, and vascular dementia. J. Cachexia Sarcopenia Muscle, 13(5), 2447–2455. https://doi.org/10.1002/jcsm.13054
Weinstein, G., O’Donnell, A., Davis-Plourde, K., Zelber-Sagi, S., Ghosh, S., DeCarli, C. S., Thibault, E. G., Sperling, R. A., Johnson, K. A., Beiser, A. S., & Seshadri, S. (2022). Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study. Journal of Alzheimer’s Disease, 86(3), 1371–1383. https://doi.org/10.3233/JAD-215409
World Health Organization. (2020). Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death
Yuan, S., & Larsson, S. C. (2023). Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metab.: Clin. Exp., 144, 155533. https://doi.org/10.1016/j.metabol.2023.155533
Zárate, S., Stevnsner, T., & Gredilla, R. (2017). Role of estrogen and other sex hormones in brain aging. Neuroprotection and DNA repair. Front. Aging Neurosci., 9, 430. https://doi.org/10.3389/fnagi.2017.00430
Zhang, J., Na, X., Li, Z., Ji, J. S., Li, G., Yang, H., Yang, Y., Tan, Y., Zhang, J., Xi, M., Su, D., Zeng, H., Wu, L., & Zhao, A. (2024). Sarcopenic obesity is part of obesity paradox in dementia development: evidence from a population-based cohort study. BMC Medicine, 22(1), 133. https://doi.org/10.1186/s12916-024-03357-4
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição-NãoComercial-SemDerivações 4.0.
Direitos de Autor (c) 2025 Dina João